Norrin-Frizzled-4-LRP5-TSPAN12 receptor complex (NDP-FZD4-LRP5-TSPAN12)

The Norrin signaling pathway receptor complex is a specialized molecular assembly primarily located on the vascular endothelial cells of the retina and inner ear. It is composed of the ligand Norrin (NDP), the primary receptor Frizzled-4 (FZD4), the co-receptor Low-density lipoprotein receptor-related protein 5 (LRP5), and the essential auxiliary protein Tetraspanin-12 (TSPAN12) [PMID: 15035990, PMID: 19710647]. This complex is critical for the activation of the canonical Wnt/beta-catenin signaling pathway, which governs the development of the retinal vasculature and the maintenance of the blood-retinal barrier [PMID: 23021217]. Genetic mutations in any component of this complex lead to severe vitreoretinal diseases, such as Norrie disease and Familial Exudative Vitreoretinopathy (FEVR), characterized by incomplete vascularization and pathological leakage [PMID: 20301500]. Therapeutically, this complex is targeted by Norrin mimetics and bispecific antibodies, such as SZN-413, which are designed to restore Wnt signaling in patients with vascular retinal disorders [Surrozen, 2023]. By stabilizing the endothelial barrier and promoting healthy vessel growth, drugs targeting this complex aim to treat conditions like diabetic retinopathy and wet age-related macular degeneration.

Other names

Norrin/beta-catenin signaling complexNDP-FZD4-LRP5 complexNorrin-Frizzled-4 signaling assemblyFZD4-LRP5-TSPAN12 complex

Agonism of the Frizzled-4 receptor and LRP5 co-receptor to activate the canonical Wnt/beta-catenin signaling pathway, promoting vascular endothelial cell stabilization and blood-retinal barrier repair.